论文部分内容阅读
编者按自从国际蛛网膜下腔出血研究公布后,动脉瘤的血管内治疗在近10余年得到了快速的发展。各种栓塞材料及方法的改进进一步提高了动脉瘤血管内治疗的安全性和有效性,扩大了血管内治疗的适应证。但是对于颅内一些特殊的动脉瘤,如复发动脉瘤及大型动脉瘤治疗仍较困难,传统以瘤内栓塞为目的的血管内治疗常伴有较高的复发率,增加了患者的经济和心理负担,也增加了患者的手术风险。
Editor’s note Since the publication of the International Journal of Subarachnoid Hemorrhage, endovascular treatment of aneurysms has seen rapid development in the past 10 years or so. Various embolic materials and methods to improve and further improve the safety and effectiveness of endovascular treatment of aneurysms, expanding the indications for endovascular treatment. However, for some special intracranial aneurysms, such as recurrent aneurysms and large aneurysms is still difficult to treat, the traditional endovascular embolization for the purpose of endovascular treatment is often accompanied by a high recurrence rate, increased patient economic and psychological The burden also increases the patient’s surgical risk.